We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.AuthorsReeder CB; Reece DE; Kukreti V; Chen C; Trudel S; Hentz J; Noble B; Pirooz NA; Spong JE; Piza JG; Zepeda VH; Mikhael JR; Leis JF; Bergsagel PL; Fonseca R; Stewart AKPublicationLeukemia, 2009, Vol 23, Issue 7, p1337ISSN1476-5551Publication typearticleDOI10.1038/leu.2009.26